{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:37:43Z","timestamp":1770745063609,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.taap.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T12:22:34Z","timestamp":1347538954000},"page":"360-367","source":"Crossref","is-referenced-by-count":24,"title":["NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I"],"prefix":"10.1016","volume":"265","author":[{"given":"Katerina","family":"Levova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Moserova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Nebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz H.","family":"Schmeiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker M.","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Stiborova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.09.004_bb0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ijc.10602","article-title":"Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?","volume":"101","author":"Arlt","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.09.004_bb0020","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/carcin\/bgm082","article-title":"Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer","volume":"28","author":"Arlt","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.09.004_bb0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/tx200259y","article-title":"Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1\u2212\/\u2212, Cyp1a2\u2212\/\u2212, and Cyp1a1\/1a2\u2212\/\u2212 mice","volume":"24","author":"Arlt","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.09.004_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.25324","article-title":"Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice","volume":"128","author":"Arlt","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.09.004_bb0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.09.004_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/toxsci\/kfr138","article-title":"Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity","volume":"122","author":"Chen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.004_bb0035","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2012.09.004_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/bbrc.1999.1913","article-title":"Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery","volume":"267","author":"Dalton","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2012.09.004_bb0055","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/carcin\/8.10.1549","article-title":"Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants","volume":"8","author":"De Long","year":"1987","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.09.004_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2012.09.004_bb0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2007.05.202","article-title":"Generation of \u2018humanized\u2019 hCYP1A1_1A2_Cyp1a1\/1a2(\u2212\/\u2212) mouse line","volume":"359","author":"Dragin","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2012.09.004_bb0065","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2012.09.004_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1470-2045(08)70286-9","article-title":"A review of human carcinogens\u2014part A: pharmaceuticals","volume":"10","author":"Grosse","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2012.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.freeradbiomed.2004.02.074","article-title":"Nrf2 signaling in coordinated activation of antioxidant gene expression","volume":"36","author":"Jaiswal","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.09.004_bb0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Jelakovic","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2012.09.004_bb0085","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/j.1742-4658.2010.07676.x","article-title":"Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model","volume":"277","author":"Kucab","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2012.09.004_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/toxsci\/kfr050","article-title":"Role of cytochromes P450 1A1\/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model","volume":"121","author":"Levova","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.004_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1432-1033.1994.tb20023.x","article-title":"Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents","volume":"226","author":"Li","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.taap.2012.09.004_bb0100","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.93.4.1671","article-title":"Cyp1a2(\u2212\/\u2212) null mutant mice develop normally but show deficient drug metabolism","volume":"93","author":"Liang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2012.09.004_bb0105","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","article-title":"DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy","volume":"43","author":"Lord","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2012.09.004_bb0110","first-page":"57","article-title":"Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases","volume":"32","author":"Martinek","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.taap.2012.09.004_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mrgentox.2010.12.003","article-title":"Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats","volume":"720","author":"Mizerovska","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ijc.26077","article-title":"TP53 Mutational signature for aristolochic acid: an environmental carcinogen","volume":"129","author":"Moriya","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.09.004_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0020-711X(89)90182-1","article-title":"Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene","volume":"3","author":"Nebert","year":"1989","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.taap.2012.09.004_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-2952(99)00310-X","article-title":"Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis","volume":"59","author":"Nebert","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.004_bb0125","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.09.004_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mrfmmm.2004.05.023","article-title":"Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix\u2013loop\u2013helix transcription factors","volume":"555","author":"Nioi","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.09.004_bb0145","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2012.09.004_bb0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrc3311","article-title":"Upper urinary tract urothelial cancer: where it is A:T","volume":"12","author":"Olivier","year":"2012","journal-title":"Nat. Rev."},{"key":"10.1016\/j.taap.2012.09.004_bb0155","first-page":"4776","article-title":"Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver","volume":"48","author":"Prochaska","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2012.09.004_bb0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1124\/dmd.110.032201","article-title":"Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse","volume":"38","author":"Rosenquist","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.09.004_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","article-title":"NAD(P)H:quinone oxidoreductase (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms","volume":"129","author":"Ross","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2012.09.004_bb0170","first-page":"2025","article-title":"Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy","volume":"56","author":"Schmeiser","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2012.09.004_bb0175","first-page":"141","article-title":"Chemical and molecular basis of the carcinogenicity of Aristolochia plants","volume":"12","author":"Schmeiser","year":"2009","journal-title":"Curr. Opin. Drug Discovery Dev."},{"key":"10.1016\/j.taap.2012.09.004_bb0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbrc.2008.09.068","article-title":"Generation of a \u2018humanized\u2019 hCYP1A1_1A2_Cyp1a1\/1a2(\u2212\/\u2212)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor","volume":"376","author":"Shi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2012.09.004_bb0185","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/ijc.25141","article-title":"Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents","volume":"127","author":"Shibutani","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.09.004_bb0190","first-page":"733","article-title":"Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid","volume":"29","author":"Sistkova","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.taap.2012.09.004_bb0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/tx010059z","article-title":"Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2","volume":"14","author":"Stiborova","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.09.004_bb0225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1135\/cccc20010959","article-title":"Isolation of DT-diaphorase [NAD(P)H dehydrogenase (quinone)] from rat liver cytosol: identification of new substrates, carcinogenic aristolochic acids","volume":"66","author":"Stiborova","year":"2001","journal-title":"Collect. Czech. Chem. Comm."},{"key":"10.1016\/j.taap.2012.09.004_bb0215","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgg119","article-title":"Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase","volume":"24","author":"Stiborova","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.09.004_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.20564","article-title":"Human hepatic and renal microsomes, cytochromes P450 1A1\/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer","volume":"113","author":"Stiborova","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.09.004_bb0195","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1124\/dmd.106.009373","article-title":"The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase","volume":"34","author":"Stiborova","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.09.004_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrrev.2007.07.003","article-title":"Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy","volume":"658","author":"Stiborova","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2012.09.004_bb0210","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2008.125","article-title":"Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid","volume":"73","author":"Stiborova","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2012.09.004_bb0235","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/em.20642","article-title":"The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases","volume":"52","author":"Stiborova","year":"2011","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2012.09.004_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/toxsci\/kfr306","article-title":"Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2","volume":"125","author":"Stiborova","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2012.09.004_bb0245","first-page":"34","article-title":"Genetic studies in BEN and associated urothelian cancers","volume":"30","author":"Toncheva","year":"2006","journal-title":"Coll. Antropol."},{"key":"10.1016\/j.taap.2012.09.004_bb0250","first-page":"384","article-title":"Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy","volume":"17","author":"Toncheva","year":"2004","journal-title":"J. Nephrol."},{"key":"10.1016\/j.taap.2012.09.004_bb0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2012.09.004_bb0260","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2008.103","article-title":"Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity","volume":"73","author":"Xiao","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2012.09.004_bb0265","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.tiv.2011.01.016","article-title":"Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1\/2 activation in human cells","volume":"25","author":"Yu","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.taap.2012.09.004_bb0270","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/tx3000889","article-title":"Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography\/ion-trap mass spectrometry","volume":"25","author":"Yun","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.09.004_bb0275","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tiv.2012.03.005","article-title":"Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells","volume":"26","author":"Zhu","year":"2012","journal-title":"Toxicol. In Vitro"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T16:22:04Z","timestamp":1542730924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12004000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0041008X12004000"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.09.004","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}